Get all your news in one place.

100’s of premium titles.
One app.

Start reading

Get all your news in one place.

100’s of premium titles. One news app.

Start reading

The Latest Breaking News from Parker Hannifin

Stocks Showing Improving Market Leadership: Parker Hannifin Earns 81 RS Rating

Parker Hannifin shows rising price performance, earning an upgrade to its IBD Relative Strength Rating from 78 to 81.

Investors Business Daily

Stocks To Watch: Parker Hannifin Sees RS Rating Rise To 81

Parker Hannifin shows rising price performance, earning an upgrade to its IBD Relative Strength Rating from 77 to 81.

Investors Business Daily

Parker Hannifin Hits 80-Plus Relative Strength Rating Benchmark

A Relative Strength Rating upgrade for Parker Hannifin shows improving technical performance.

Investors Business Daily

From analysis to the latest developments in health,
read the most diverse news in one place.

Pro-Palestine activists target Glasgow factory in Gaza protest

Pro-Palestine campaigners have targeted a factory in Glasgow which supplies parts to a weapons manufacturer used by Israeli forces in Gaza.

The National (Scotland)

Parker Hannifin Stock: A Deep Dive Into Analyst Perspectives (14 Ratings)

In the latest quarter, 14 analysts provided ratings for Parker Hannifin (NYSE:PH), showcasing a mix of bullish and bearish perspectives.

Benzinga

Stock Market Movers: These Two Industrial Stocks Rally Sharply On Earnings

Parker Hannifin and Aspen Aerogels both surged early Thursday after surprising analysts with quarterly results.

Investors Business Daily

S&P 500 Giants Lead Stocks Near Buy Points; Can They Hold Up Amid The Market Pullback?

S&P 500 components Paccar and Parker Hannifin lead a group of five stocks trading right around entry points.

Investors Business Daily

Read news from The Economist, FT, and more,
with one subscription

Parker Hannifin makes multimillion-dollar investment into Birtley Bioscience Filtration site

The investment comes as the firm sees growing demand from the pharmaceutical, biopharmaceutical, and food and beverage industries

Birmingham Post

If You Invested $100 In This Stock 20 Years Ago, You Would Have $800 Today

Parker Hannifin (NYSE:PH) has outperformed the market over the past 20 years by 3.83% on an annualized basis producing an average annual return of 10.91%. Currently, Parker Hannifin has a market capitalization of $31.43 billion.

Benzinga

UK government ‘minded to accept’ takeover of Meggitt by US buyer

Parker Hannifin expects to complete £6.3bn move for British defence manufacturer within two months

The Guardian - UK

What 6 Analyst Ratings Have To Say About Parker Hannifin

Over the past 3 months, 6 analysts have published their opinion on Parker Hannifin (NYSE:PH) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.

Benzinga

Peering Into Parker Hannifin's Recent Short Interest

Parker Hannifin's (NYSE:PH) short percent of float has risen 30.0% since its last report. The company recently reported that it has 1.66 million shares sold short, which is 1.3% of all regular shares that are available for trading.

Benzinga

Here's How Much You Would Have Made Owning Parker Hannifin Stock In The Last 15 Years

Parker Hannifin (NYSE:PH) has outperformed the market over the past 15 years by 3.05% on an annualized basis producing an average annual return of 9.32%. Currently, Parker Hannifin has a market capitalization of $32.67 billion.

Benzinga

$1000 Invested In Parker Hannifin 20 Years Ago Would Be Worth This Much

Parker Hannifin (NYSE:PH) has outperformed the market over the past 20 years by 4.31% on an annualized basis producing an average annual return of 11.53%. Currently, Parker Hannifin has a market capitalization of $35.40 billion.

Benzinga

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

Parker Hannifin's Return on Invested Capital Insights

Pulled from Benzinga Pro data, Parker Hannifin (NYSE:PH) showed a loss in earnings since Q2, totaling $348.09 million. Sales, on the other hand, increased by 6.82% to $4.09 billion during Q3.

Benzinga

7 Analysts Have This to Say About Parker Hannifin

Over the past 3 months, 7 analysts have published their opinion on Parker Hannifin (NYSE:PH) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.

Benzinga

Parker Hannifin: Q3 Earnings Insights

Parker Hannifin (NYSE:PH) reported its Q3 earnings results on Thursday, May 5, 2022 at 07:30 AM. Here's what investors need to know about the announcement.

Benzinga

Where Parker Hannifin Stands With Analysts

Within the last quarter, Parker Hannifin (NYSE:PH) has observed the following analyst ratings:

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

A Bearish Sign Appears On Parker Hannifin's Chart

If history is any guide, there may be trouble ahead for shares of Parker Hannifin (NYSE:PH). A so-called "death cross" has formed on its chart and, not surprisingly, this could be bearish for the stock.

Benzinga

Parker Hannifin Earnings Perspective: Return On Invested Capital

According to Benzinga Pro data Parker Hannifin (NYSE:PH) posted a 14.12% decrease in earnings from Q1. Sales, however, increased by 1.65% over the previous quarter to $3.83 billion.

Benzinga

Parker-Hannifin Clocks 12% Revenue Growth In Q2; Raises FY22 Guidance

Parker-Hannifin Corp (NYSE:PH) reported second-quarter FY22 sales growth of 12% year-over-year to $3.82 billion and +13% on an organic basis, beating the consensus of $3.72 billion. Adjusted EPS improved to $4.46 from $3.45 in 2Q21, beating the consensus of $3.91. Parker Hannifin generated a YTD operating cash flow of $1.01 billion, compared to…

Benzinga

Parker Hannifin: Q2 Earnings Insights

Parker Hannifin (NYSE:PH) reported its Q2 earnings results on Thursday, February 3, 2022 at 07:30 AM. Here's what investors need to know about the announcement.

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.